4A79
Crystal structure of human monoamine oxidase B (MAO B) in complex with pioglitazone
Summary for 4A79
Entry DOI | 10.2210/pdb4a79/pdb |
Related | 1GOS 1H8R 1OJ9 1OJA 1OJC 1OJD 1S2Q 1S2Y 1S3B 1S3E 2BK3 2BK4 2BK5 2BYB 2C64 2C65 2C66 2C67 2C70 2C72 2C73 2C75 2C76 2V5Z 2V60 2V61 2VRL 2VRM 2VZ2 2XCG 2XFN 2XFO 2XFP 2XFQ 2XFU 3ZYX 4A7A |
Descriptor | AMINE OXIDASE [FLAVIN-CONTAINING] B, FLAVIN-ADENINE DINUCLEOTIDE, (5R)-5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione, ... (4 entities in total) |
Functional Keywords | oxidoreductase, anti-diabetes drug, parkinson's disease, neurodegeneration |
Biological source | HOMO SAPIENS (HUMAN) |
Cellular location | Mitochondrion outer membrane; Single-pass type IV membrane protein; Cytoplasmic side: P27338 |
Total number of polymer chains | 2 |
Total formula weight | 119959.44 |
Authors | Binda, C.,Aldeco, M.,Geldenhuys, W.J.,Tortorici, M.,Mattevi, A.,Edmondson, D.E. (deposition date: 2011-11-11, release date: 2012-04-25, Last modification date: 2023-12-20) |
Primary citation | Binda, C.,Aldeco, M.,Geldenhuys, W.J.,Tortorici, M.,Mattevi, A.,Edmondson, D.E. Molecular Insights Into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs Acs Med. Chem. Lett., 3:39-42-, 2012 Cited by PubMed: 22282722DOI: 10.1021/ML200196P PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.89 Å) |
Structure validation
Download full validation report